药渡2018-05-13 21:48
在2018年3月19日至22日召开的人用药物委员会会议(CHMP)会议上,欧洲药品管理局(EMA)拒绝了两种于2017年已获得FDA批准的药物:Portola药业的血栓新药Dexxience (Betrixaban,贝曲西班)和Radius International公司的骨质疏松症治疗药物Eladynos (Abaloparatide,安巴洛他定)。
Dexxience
201...查看全文
非洲人咸猪手2018-05-10 17:46
$Portola制药(PTLA)$ 其实William Lis自己心里也应该有点逼数,他自己以及这个mgmt有多incompetent。BO是唯一出路吧,别毁了那么好的资产和自己手里的最后一手好牌。查看全文
$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040371 Size: 12 KB 网页链接
$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040380 Size: 16 KB 网页链接
$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040346 Size: 20 KB 网页链接
$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040356 Size: 8 KB 网页链接
$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040364 Size: 13 KB 网页链接
$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040326 Size: 23 KB 网页链接
$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040332 Size: 10 KB 网页链接
$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040341 Size: 25 KB 网页链接
$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040307 Size: 23 KB 网页链接
$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040311 Size: 12 KB 网页链接